SUNPHARMA:NSE
Sun Pharmaceutical Industries Ltd
₹ १,७५८.८०
arrow_downward
-०.२९%(-५.२०) 1D
अक्टोबर १६, १५:३०:०० GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SUNPHARMA...
Open
₹ १,७६२.२०
High
₹ १,७६४.९०
Low
₹ १,७४३.५०
Mkt. cap
४२.२० खरब
Avg. vol.
१४.५० लाख
Volume
१५.२२ लाख
Dividend
०.९१%
Quarterly dividend
₹ ४.००
Ex-dividend date
२०२६ जुलाई ७
P/E ratio
३४.८७
52-wk high
₹ २,०४६.९०
52-wk low
₹ १,५८३.७०
EPS
₹ ५०.४४
Shares outstanding
०.००
No. of employees
४७ हजार
Open
₹ १,७६२.२०
High
₹ १,७६४.९०
Low
₹ १,७४३.५०
Mkt. cap
४२.२० खरब
Avg. vol.
१४.५० लाख
Volume
१५.२२ लाख
Dividend
०.९१%
Quarterly dividend
₹ ४.००
Ex-dividend date
२०२६ जुलाई ७
P/E ratio
३४.८७
52-wk high
₹ २,०४६.९०
52-wk low
₹ १,५८३.७०
EPS
₹ ५०.४४
Shares outstanding
०.००
No. of employees
४७ हजार
News stories
From web sources and news partners
ad-hoc-news.de
·
६ घण्टा पहिले
Sun Pharma stock: Results are due October 29 for Sun Pharma stock
ad-hoc-news.de
·
११ घण्टा पहिले
Crisil rates Sun Pharma debt AAA. Sun Pharma stock is valued at INR 4.2 trillion
ad-hoc-news.de
·
१ दिन पहिले
Analyst consensus puts Sun Pharma stock at INR 2,180.00
Moneycontrol.com
·
२ दिन पहिले
Sun Pharma: Tariff relief, innovation brighten growth outlook
Profile
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
About Sun Pharmaceutical Industries Ltd